Effect of Binge-Drinking on Quality of Life in the 'Seguimiento Universidad de Navarra' (SUN) Cohort.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
21 Feb 2023
Historique:
received: 17 01 2023
revised: 09 02 2023
accepted: 14 02 2023
entrez: 11 3 2023
pubmed: 12 3 2023
medline: 15 3 2023
Statut: epublish

Résumé

Binge-drinking is one of the alcohol drinking patterns with the worst health consequences. Nonetheless, binge-drinking is highly prevalent. The perceived benefits that motivate it are ultimately related to subjective well-being. In this context, we analyzed the relationship between binge-drinking and quality of life. We evaluated 8992 participants of the SUN cohort. We classified as binge-drinkers those who reported consuming six or more drinks on at least one occasion the year before recruitment ( Binge-drinking was associated with greater odds of having a worse mental quality of life, even adjusting for quality of life at 4 years of follow-up, used as an approximation to a baseline measure (OR = 1.22 (1.07-1.38)). This value was mainly due to the effects on vitality (OR = 1.17 (1.01-1.34)) and mental health (OR = 1.22 (1.07-1.39)). Binge-drinking may lead to poorer mental quality of life; therefore, binge-drinking for enhancement purposes does not seem to be justified by this effect.

Sections du résumé

BACKGROUND BACKGROUND
Binge-drinking is one of the alcohol drinking patterns with the worst health consequences. Nonetheless, binge-drinking is highly prevalent. The perceived benefits that motivate it are ultimately related to subjective well-being. In this context, we analyzed the relationship between binge-drinking and quality of life.
METHODS METHODS
We evaluated 8992 participants of the SUN cohort. We classified as binge-drinkers those who reported consuming six or more drinks on at least one occasion the year before recruitment (
RESULTS RESULTS
Binge-drinking was associated with greater odds of having a worse mental quality of life, even adjusting for quality of life at 4 years of follow-up, used as an approximation to a baseline measure (OR = 1.22 (1.07-1.38)). This value was mainly due to the effects on vitality (OR = 1.17 (1.01-1.34)) and mental health (OR = 1.22 (1.07-1.39)).
CONCLUSIONS CONCLUSIONS
Binge-drinking may lead to poorer mental quality of life; therefore, binge-drinking for enhancement purposes does not seem to be justified by this effect.

Identifiants

pubmed: 36904072
pii: nu15051072
doi: 10.3390/nu15051072
pmc: PMC10004732
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Plan Nacional Sobre Drogas
ID : 2020/021
Organisme : Instituto de Salud Carlos III
ID : PI20/00564

Références

Br J Nutr. 2010 Jun;103(12):1808-16
pubmed: 20102675
Addict Behav. 2016 Oct;61:91-8
pubmed: 27253155
JAMA Pediatr. 2013 Jul;167(7):634-9
pubmed: 23712747
N Engl J Med. 2003 Jun 26;348(26):2599-608
pubmed: 12826634
Psychol Health. 2017 Aug;32(8):976-1017
pubmed: 28513195
Alcohol Res. 2018;39(1):87-96
pubmed: 30557151
Public Health Nutr. 2010 Sep;13(9):1364-72
pubmed: 20105389
J Subst Use. 2021;26(6):650-656
pubmed: 34899050
Public Health Nutr. 2006 Feb;9(1A):127-31
pubmed: 16512960
Addiction. 2009 Jul;104(7):1168-78
pubmed: 19438420
Int J Environ Res Public Health. 2021 Aug 31;18(17):
pubmed: 34501790
Drug Alcohol Depend. 2016 Apr 1;161:86-94
pubmed: 26868863
Prev Chronic Dis. 2012;9:E86
pubmed: 22498037
Nutrients. 2018 Mar 31;10(4):
pubmed: 29614726
Alcohol Clin Exp Res. 1997 Aug;21(5):899-905
pubmed: 9267541
Public Health Nutr. 2005 Oct;8(7):920-7
pubmed: 16277809
Am J Prev Med. 2015 Nov;49(5):e73-e79
pubmed: 26477807
Lancet. 2020 Oct 17;396(10258):1223-1249
pubmed: 33069327
Drug Alcohol Depend. 2018 Dec 1;193:48-54
pubmed: 30340145
Alcohol Alcohol. 2011 Jul-Aug;46(4):393-8
pubmed: 21493639
Addict Behav. 2011 Dec;36(12):1240-5
pubmed: 21868171
Am J Prev Med. 2004 Apr;26(3):230-3
pubmed: 15026103
Int J Epidemiol. 1993 Jun;22(3):512-9
pubmed: 8359969
Liver Transpl. 2006 Jan;12(1):95-104
pubmed: 16382456
Gac Sanit. 2005 Mar-Apr;19(2):135-50
pubmed: 15860162
Clin Psychol Rev. 2005 Nov;25(7):841-61
pubmed: 16095785
Med Clin (Barc). 2008 May 24;130(19):726-35
pubmed: 18570798
Eur J Public Health. 2017 Aug 1;27(4):692-699
pubmed: 28431128
BMJ Open. 2017 May 4;7(4):e014368
pubmed: 28473511
J Adv Nurs. 2016 Sep;72(9):2098-113
pubmed: 27102085
Addict Behav. 2020 Jan;100:106114
pubmed: 31493692
Alcohol Clin Exp Res. 2015 Apr;39(4):688-96
pubmed: 25787314
Sci Rep. 2019 Jul 18;9(1):10401
pubmed: 31320663
Addiction. 2010 May;105(5):817-43
pubmed: 20331573
Alcohol Res. 2018;39(1):99-109
pubmed: 30557153

Auteurs

Rafael Perez-Araluce (R)

Department of Preventive Medicine and Public Health, University of Navarra, 31008 Pamplona, Spain.
Instituto de Investigación Sanitaria de Navarra (IdiSNA), Navarra Institute for Health Research, 31008 Pamplona, Spain.

Maira Bes-Rastrollo (M)

Department of Preventive Medicine and Public Health, University of Navarra, 31008 Pamplona, Spain.
Instituto de Investigación Sanitaria de Navarra (IdiSNA), Navarra Institute for Health Research, 31008 Pamplona, Spain.
Biomedical Research Network Center for Pathophysiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain.

Miguel Ángel Martínez-González (MÁ)

Department of Preventive Medicine and Public Health, University of Navarra, 31008 Pamplona, Spain.
Instituto de Investigación Sanitaria de Navarra (IdiSNA), Navarra Institute for Health Research, 31008 Pamplona, Spain.
Biomedical Research Network Center for Pathophysiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain.

Estefanía Toledo (E)

Department of Preventive Medicine and Public Health, University of Navarra, 31008 Pamplona, Spain.
Instituto de Investigación Sanitaria de Navarra (IdiSNA), Navarra Institute for Health Research, 31008 Pamplona, Spain.
Biomedical Research Network Center for Pathophysiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain.

Miguel Ruiz-Canela (M)

Department of Preventive Medicine and Public Health, University of Navarra, 31008 Pamplona, Spain.
Instituto de Investigación Sanitaria de Navarra (IdiSNA), Navarra Institute for Health Research, 31008 Pamplona, Spain.
Biomedical Research Network Center for Pathophysiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain.

María Barbería-Latasa (M)

Department of Preventive Medicine and Public Health, University of Navarra, 31008 Pamplona, Spain.
Instituto de Investigación Sanitaria de Navarra (IdiSNA), Navarra Institute for Health Research, 31008 Pamplona, Spain.

Alfredo Gea (A)

Department of Preventive Medicine and Public Health, University of Navarra, 31008 Pamplona, Spain.
Instituto de Investigación Sanitaria de Navarra (IdiSNA), Navarra Institute for Health Research, 31008 Pamplona, Spain.
Biomedical Research Network Center for Pathophysiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH